Important Information for Sage Therapeutics Investors
Are you an investor in Sage Therapeutics, Inc. (NASDAQ: SAGE) who has experienced significant losses? If so, it’s crucial that you pay attention to the upcoming October 28 deadline. A securities class action has been initiated that might provide you with an opportunity for compensation without incurring out-of-pocket expenses.
Why You Should Consider Legal Counsel
The Rosen Law Firm, a respected name in investor rights, is reminding all investors who purchased Sage securities between April 12, 2021, and July 23, 2024, of the importance of securing counsel. Being part of this class action could facilitate compensation for your losses, and the firm emphasizes that this can be achieved with a contingency fee arrangement.
What Steps Should You Take?
To participate in the Sage class action lawsuit, it is advisable to reach out directly to the Rosen Law Firm. Potential claimants can contact Phillip Kim, Esq., toll-free at 866-767-3653 or email the firm for more information. This is an essential step for those who would like to act before the deadline.
The Case Details Explained
There are significant allegations surrounding Pragmatic Therapeutics. The multinational law firm claims that during the class period, the firm made numerous false statements and did not disclose critical information regarding its products. These misleading statements primarily revolved around the efficacy of their leading drugs such as zuranolone, SAGE-718, and SAGE-324.
What Were the Allegations?
The lawsuit asserts that Sage Therapeutics overstated the effectiveness of its drugs used to treat conditions like postpartum depression and major depressive disorder. More precisely, it alleges that the FDA is unlikely to approve their new drug application (NDA) for these treatments, contradicting the public statements made by the company.
The Importance of Selecting Experienced Counsel
Securities class actions can be complex and lengthy. Investors are advised to choose a law firm with a strong history in this field. The Rosen Law Firm has achieved notable success in numerous securities class actions, which emphasizes the importance of expert legal representation in ensuring that your interests are effectively advocated.
Why Choose the Rosen Law Firm?
Investors are encouraged to consider firms with a proven track record in litigating securities class actions. In 2019, for instance, the firm recovered over $438 million for its clients. Their reputation for excellence has been recognized multiple times, having ranked No. 1 for class action settlements against companies in prior years.
How Can You Stay Updated?
For updates, it's possible to follow the Rosen Law Firm on social media platforms, including LinkedIn, Twitter, and Facebook. This ensures that investors are kept informed on the developments of the case and can stay connected with other stakeholders.
Frequently Asked Questions
What is the significance of the October 28 deadline?
The deadline is crucial for investors who wish to be part of the class action and potentially seek compensation for their losses.
How can I join the Sage Therapeutics class action?
You can contact the Rosen Law Firm directly via phone or email to express your interest in joining the class action.
What are the potential outcomes of this lawsuit?
If successful, the lawsuit could result in compensation for investors who have suffered financial losses during the specified class period.
When will the court decide on the class status?
The court will determine whether to certify the class after evaluating the case, and this process can take time.
Do I need to hire a lawyer now, or can I wait?
You can remain an absent class member, but hiring a lawyer may strengthen your case and ensure you understand your rights effectively.
